Author:
Shea Sue,Lionis Christos,Kite Chris,Lagojda Lukasz,Uthman Olalekan A.,Dallaway Alexander,Atkinson Lou,Chaggar Surinderjeet S.,Randeva Harpal S.,Kyrou Ioannis
Abstract
BackgroundNon-alcoholic fatty liver disease (NAFLD) is a common chronic liver disease, affecting 25-30% of the general population globally. The condition is even more prevalent in individuals with obesity and is frequently linked to the metabolic syndrome. Given the known associations between the metabolic syndrome and common mental health issues, it is likely that such a relationship also exists between NAFLD and mental health problems. However, studies in this field remain limited. Accordingly, the aim of this systematic review and meta-analysis was to explore the prevalence of one or more common mental health conditions (i.e., depression, anxiety, and/or stress) in adults with NAFLD.MethodsPubMed, EBSCOhost, ProQuest, Ovid, Web of Science, and Scopus were searched in order to identify studies reporting the prevalence of depression, anxiety, and/or stress among adults with NAFLD. A random-effects model was utilized to calculate the pooled prevalence and confidence intervals for depression, anxiety and stress.ResultsIn total, 31 studies were eligible for inclusion, involving 2,126,593 adults with NAFLD. Meta-analyses yielded a pooled prevalence of 26.3% (95% CI: 19.2 to 34) for depression, 37.2% (95% CI: 21.6 to 54.3%) for anxiety, and 51.4% (95% CI: 5.5 to 95.8%) for stress among adults with NAFLD.ConclusionThe present findings suggest a high prevalence of mental health morbidity among adults with NAFLD. Given the related public health impact, this finding should prompt further research to investigate such associations and elucidate potential associations between NAFLD and mental health morbidity, exploring potential shared underlying pathophysiologic mechanisms.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier CRD42021288934.
Reference94 articles.
1. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link;Asrih;Mol Cell Endocrinol,2015
2. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030;Estes;J Hepatol,2018
3. Recent epidemiology of nonalcoholic fatty liver disease;Murag;Gut Liver,2021
4. Clinical problems caused by obesity;Kyrou,2018
5. Nonalcoholic fatty liver disease: an emerging modern-day risk factor for cardiovascular disease;Hassen;Cureus,2022